Discontinued — last reported Q2 '22
Agilent Technologies Short-Term Borrowings remained flat by 0.0% to $304.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1800.0%, from $16.00M to $304.00M. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows an upward trend with a 32.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q1 '21 | Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $205.00M | $130.00M | $0.00 | $175.00M | $180.00M | $36.00M | $238.00M | $0.00 | $55.00M | $0.00 | $420.00M | $795.00M | $45.00M | $16.00M | $146.00M | $59.00M | $304.00M | $304.00M |
| QoQ Change | — | -36.6% | -100.0% | — | +2.9% | -80.0% | +561.1% | -100.0% | — | -100.0% | — | +89.3% | -94.3% | -64.4% | +812.5% | -59.6% | +415.3% | +0.0% |
| YoY Change | — | — | — | -14.6% | +38.5% | — | — | -100.0% | -69.4% | -100.0% | — | >999% | — | — | -65.2% | -92.6% | +575.6% | >999% |